| Term | Count | PValue | Genes |
| rno04114: Oocyte meiosis | 6 | 2.47E-04 | P63102, P62161, P35213, A0A0H2UHV6, P63086, P11275 | rno05010: Alzheimer’s disease | 6 | 0.00251 | P62161, P10818, D4A0T0, A0A0H2UHV6, P63086, P37377 | rno05012: Parkinson’s disease | 5 | 0.008091 | O88767, Q09073, P10818, D4A0T0, P37377 | rno04921: Oxytocin signaling pathway | 5 | 0.009657 | P61589, P62161, A0A0H2UHV6, P63086, P11275 | rno04022: cGMP-PKG signaling pathway | 5 | 0.011878 | P61589, P62161, Q09073, A0A0H2UHV6, P63086 | rno05152: Tuberculosis | 5 | 0.014949 | P61589, P62161, A0A0H2UHV6, P63086, P11275 | rno05014: Amyotrophic lateral sclerosis (ALS) | 4 | 0.002947 | P19527, P12839, A0A0H2UHV6, F1LRZ7 | rno04721: Synaptic vesicle cycle | 4 | 0.004142 | F1LQ81, P21707, F1M779, F1M378 | rno04720: Long-term potentiation | 4 | 0.004732 | P62161, A0A0H2UHV6, P63086, P11275 | rno01200: Carbon metabolism | 4 | 0.025472 | P05708, Q6P6R2, P14604, P08461 | rno04722: Neurotrophin signaling pathway | 4 | 0.028277 | P61589, P62161, P63086, P11275 | rno05020: Prion diseases | 3 | 0.012162 | P06761, A0A0G2K0M8, P63086 | rno05031: Amphetamine addiction | 3 | 0.044482 | P62161, A0A0H2UHV6, P11275 | rno05214: Glioma | 3 | 0.045744 | P62161, P63086, P11275 |
|
|